La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Bioceres Crop Solutions Résultats passés
Passé contrôle des critères 2/6
Bioceres Crop Solutions has been growing earnings at an average annual rate of 56.3%, while the Chemicals industry saw earnings growing at 13.1% annually. Revenues have been growing at an average rate of 25.7% per year. Bioceres Crop Solutions's return on equity is 1.6%, and it has net margins of 0.7%.
Informations clés
56.3%
Taux de croissance des bénéfices
60.6%
Taux de croissance du BPA
| Chemicals Croissance de l'industrie | 12.9% |
| Taux de croissance des recettes | 25.7% |
| Rendement des fonds propres | 1.6% |
| Marge nette | 0.7% |
| Dernière mise à jour des bénéfices | 31 Mar 2024 |
Mises à jour récentes des performances passées
Recent updates
These 4 Measures Indicate That Bioceres Crop Solutions (NASDAQ:BIOX) Is Using Debt Extensively
Aug 03
Bioceres Needs To Add Clarity Around Borrowings
Mar 23Bioceres Crop Solutions (NASDAQ:BIOX) Takes On Some Risk With Its Use Of Debt
Feb 03Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?
Oct 04Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Popularity With Investors Is Clear
Jun 21Here's Why Bioceres Crop Solutions (NASDAQ:BIOX) Is Weighed Down By Its Debt Load
May 09Bioceres: A Resilient Small Cap With Conference Appearances After Thursday's Earnings
Sep 06Bioceres Crop Solutions jumps 15% after investor pitch
Aug 23We Think Bioceres Crop Solutions (NASDAQ:BIOX) Is Taking Some Risk With Its Debt
Apr 10Bioceres Has Not Resolved Its Major Risks And Is Growing Based On Commodities Bullishness
Mar 31Is Now The Time To Look At Buying Bioceres Crop Solutions Corp. (NASDAQ:BIOX)?
Mar 17Is Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Trading At A 21% Discount?
Nov 13Bioceres Crop Solutions (NASDAQ:BIOX) Shareholders Will Want The ROCE Trajectory To Continue
Jul 08Estimating The Intrinsic Value Of Bioceres Crop Solutions Corp. (NASDAQ:BIOX)
Jun 16What Does Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Share Price Indicate?
May 26Bioceres partners with Havanna to offer consumers HB4 wheat-based sustainable products
May 10Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?
May 05Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Will Want The ROCE Trajectory To Continue
Apr 05Are Investors Undervaluing Bioceres Crop Solutions Corp. (NYSEMKT:BIOX) By 22%?
Mar 10Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Booked A 53% Gain In The Last Year
Feb 12Ventilation des recettes et des dépenses
Comment Bioceres Crop Solutions gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 31 Mar 24 | 446 | 3 | 106 | 16 |
| 31 Dec 23 | 455 | 22 | 104 | 16 |
| 30 Sep 23 | 409 | 14 | 102 | 16 |
| 30 Jun 23 | 419 | 19 | 99 | 15 |
| 31 Mar 23 | 416 | 15 | 95 | 13 |
| 31 Dec 22 | 391 | -19 | 88 | 11 |
| 30 Sep 22 | 389 | -8 | 78 | 9 |
| 30 Jun 22 | 328 | -7 | 65 | 7 |
| 31 Mar 22 | 308 | -2 | 58 | 7 |
| 31 Dec 21 | 275 | 4 | 52 | 6 |
| 30 Sep 21 | 231 | 1 | 46 | 6 |
| 30 Jun 21 | 207 | -7 | 45 | 6 |
| 31 Mar 21 | 174 | -5 | 37 | 4 |
| 31 Dec 20 | 164 | -7 | 35 | 4 |
| 30 Sep 20 | 178 | 3 | 34 | 4 |
| 30 Jun 20 | 172 | 3 | 33 | 4 |
| 31 Mar 20 | 174 | 0 | 36 | 5 |
| 31 Dec 19 | 167 | -18 | 36 | 5 |
| 30 Sep 19 | 167 | -23 | 36 | 4 |
| 30 Jun 19 | 160 | -18 | 34 | 4 |
| 31 Mar 19 | 142 | -26 | 29 | 3 |
| 31 Dec 18 | 145 | -8 | 28 | 3 |
| 30 Sep 18 | 129 | -13 | 29 | 4 |
| 30 Jun 18 | 133 | -11 | 31 | 4 |
| 30 Jun 17 | 94 | -12 | 27 | 4 |
| 31 Dec 16 | 41 | -6 | 8 | 1 |
| 31 Dec 15 | 5 | -1 | 1 | 0 |
Des revenus de qualité: BIOX has high quality earnings.
Augmentation de la marge bénéficiaire: BIOX's current net profit margins (0.7%) are lower than last year (3.7%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: BIOX has become profitable over the past 5 years, growing earnings by 56.3% per year.
Accélération de la croissance: BIOX's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Bénéfices par rapport au secteur d'activité: BIOX had negative earnings growth (-80.2%) over the past year, making it difficult to compare to the Chemicals industry average (-4.8%).
Rendement des fonds propres
ROE élevé: BIOX's Return on Equity (1.6%) is considered low.